133 related articles for article (PubMed ID: 26927834)
1. Effects of thromboprophylaxis on mesenchymal stromal cells during osteogenic differentiation: an in-vitro study comparing enoxaparin with rivaroxaban.
Pilge H; Fröbel J; Mrotzek SJ; Fischer JC; Prodinger PM; Zilkens C; Bittersohl B; Krauspe R
BMC Musculoskelet Disord; 2016 Mar; 17():108. PubMed ID: 26927834
[TBL] [Abstract][Full Text] [Related]
2. Enoxaparin and rivaroxaban have different effects on human mesenchymal stromal cells in the early stages of bone healing.
Pilge H; Fröbel J; Prodinger PM; Mrotzek SJ; Fischer JC; Zilkens C; Bittersohl B; Krauspe R
Bone Joint Res; 2016 Mar; 5(3):95-100. PubMed ID: 26989119
[TBL] [Abstract][Full Text] [Related]
3. The effect of a new direct Factor Xa inhibitor on human osteoblasts: an in-vitro study comparing the effect of rivaroxaban with enoxaparin.
Solayar GN; Walsh PM; Mulhall KJ
BMC Musculoskelet Disord; 2011 Oct; 12():247. PubMed ID: 22035050
[TBL] [Abstract][Full Text] [Related]
4. Does Anticoagulant Medication Alter Fracture-Healing? A Morphological and Biomechanical Evaluation of the Possible Effects of Rivaroxaban and Enoxaparin Using a Rat Closed Fracture Model.
Prodinger PM; Burgkart R; Kreutzer K; Liska F; Pilge H; Schmitt A; Knödler M; Holzapfel BM; Hapfelmeier A; Tischer T; Bissinger O
PLoS One; 2016; 11(7):e0159669. PubMed ID: 27455072
[TBL] [Abstract][Full Text] [Related]
5. Osteogenic differentiation and proliferation of bone marrow-derived mesenchymal stromal cells on PDLLA + BMP-2-coated titanium alloy surfaces.
Haversath M; Hülsen T; Böge C; Tassemeier T; Landgraeber S; Herten M; Warwas S; Krauspe R; Jäger M
J Biomed Mater Res A; 2016 Jan; 104(1):145-54. PubMed ID: 26268470
[TBL] [Abstract][Full Text] [Related]
6. Berberine promotes bone marrow-derived mesenchymal stem cells osteogenic differentiation via canonical Wnt/β-catenin signaling pathway.
Tao K; Xiao D; Weng J; Xiong A; Kang B; Zeng H
Toxicol Lett; 2016 Jan; 240(1):68-80. PubMed ID: 26478571
[TBL] [Abstract][Full Text] [Related]
7. Artificial matrices with high-sulfated glycosaminoglycans and collagen are anti-inflammatory and pro-osteogenic for human mesenchymal stromal cells.
Hempel U; Matthäus C; Preissler C; Möller S; Hintze V; Dieter P
J Cell Biochem; 2014 Sep; 115(9):1561-71. PubMed ID: 24706396
[TBL] [Abstract][Full Text] [Related]
8. Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies.
Fisher WD; Eriksson BI; Bauer KA; Borris L; Dahl OE; Gent M; Haas S; Homering M; Huisman MV; Kakkar AK; Kälebo P; Kwong LM; Misselwitz F; Turpie AG
Thromb Haemost; 2007 Jun; 97(6):931-7. PubMed ID: 17549294
[TBL] [Abstract][Full Text] [Related]
9. Surface charge regulation of osteogenic differentiation of mesenchymal stem cell on polarized ferroelectric crystal substrate.
Li J; Mou X; Qiu J; Wang S; Wang D; Sun D; Guo W; Li D; Kumar A; Yang X; Li A; Liu H
Adv Healthc Mater; 2015 May; 4(7):998-1003. PubMed ID: 25663267
[TBL] [Abstract][Full Text] [Related]
10. BMP-2 Derived Peptide and Dexamethasone Incorporated Mesoporous Silica Nanoparticles for Enhanced Osteogenic Differentiation of Bone Mesenchymal Stem Cells.
Zhou X; Feng W; Qiu K; Chen L; Wang W; Nie W; Mo X; He C
ACS Appl Mater Interfaces; 2015 Jul; 7(29):15777-89. PubMed ID: 26133753
[TBL] [Abstract][Full Text] [Related]
11. Bortezomib enhances the osteogenic differentiation capacity of human mesenchymal stromal cells derived from bone marrow and placental tissues.
Sanvoranart T; Supokawej A; Kheolamai P; U-Pratya Y; Klincumhom N; Manochantr S; Wattanapanitch M; Issaragrisil S
Biochem Biophys Res Commun; 2014 May; 447(4):580-5. PubMed ID: 24747566
[TBL] [Abstract][Full Text] [Related]
12. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.
Lassen MR; Ageno W; Borris LC; Lieberman JR; Rosencher N; Bandel TJ; Misselwitz F; Turpie AG;
N Engl J Med; 2008 Jun; 358(26):2776-86. PubMed ID: 18579812
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the effects of Enoxaparin, Fondaparinux, and Rivaroxaban used in thromboembolism prophylaxis on fracture healing in rats.
Demirtas A; Azboy I; Bulut M; Ucar BY; Alabalik U; Necmioglu NS
Eur Rev Med Pharmacol Sci; 2013 Jul; 17(14):1850-6. PubMed ID: 23877846
[TBL] [Abstract][Full Text] [Related]
14. Age-related CXC chemokine receptor-4-deficiency impairs osteogenic differentiation potency of mouse bone marrow mesenchymal stromal stem cells.
Guang LG; Boskey AL; Zhu W
Int J Biochem Cell Biol; 2013 Aug; 45(8):1813-20. PubMed ID: 23742988
[TBL] [Abstract][Full Text] [Related]
15. Platelet-Derived Growth Factor BB Enhances Osteogenesis of Adipose-Derived But Not Bone Marrow-Derived Mesenchymal Stromal/Stem Cells.
Hung BP; Hutton DL; Kozielski KL; Bishop CJ; Naved B; Green JJ; Caplan AI; Gimble JM; Dorafshar AH; Grayson WL
Stem Cells; 2015 Sep; 33(9):2773-84. PubMed ID: 26013357
[TBL] [Abstract][Full Text] [Related]
16. Loss of myostatin (GDF8) function increases osteogenic differentiation of bone marrow-derived mesenchymal stem cells but the osteogenic effect is ablated with unloading.
Hamrick MW; Shi X; Zhang W; Pennington C; Thakore H; Haque M; Kang B; Isales CM; Fulzele S; Wenger KH
Bone; 2007 Jun; 40(6):1544-53. PubMed ID: 17383950
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of bioactive polyvinylpyrrolidone-iodine within bilayered collagen scaffolds enhances the differentiation and subchondral osteogenesis of mesenchymal stem cells.
Jiang Y; Chen L; Zhang S; Tong T; Zhang W; Liu W; Xu G; Tuan RS; Heng BC; Crawford R; Xiao Y; Ouyang HW
Acta Biomater; 2013 Sep; 9(9):8089-98. PubMed ID: 23707501
[TBL] [Abstract][Full Text] [Related]
18. The effect of electromagnetic fields on the proliferation and the osteogenic or adipogenic differentiation of mesenchymal stem cells modulated by dexamethasone.
Song M; Zhao D; Wei S; Liu C; Liu Y; Wang B; Zhao W; Yang K; Yang Y; Wu H
Bioelectromagnetics; 2014 Oct; 35(7):479-90. PubMed ID: 25145543
[TBL] [Abstract][Full Text] [Related]
19. Sulfated hyaluronan/collagen I matrices enhance the osteogenic differentiation of human mesenchymal stromal cells in vitro even in the absence of dexamethasone.
Hempel U; Möller S; Noack C; Hintze V; Scharnweber D; Schnabelrauch M; Dieter P
Acta Biomater; 2012 Nov; 8(11):4064-72. PubMed ID: 22771456
[TBL] [Abstract][Full Text] [Related]
20. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
Cho HH; Park HT; Kim YJ; Bae YC; Suh KT; Jung JS
J Cell Biochem; 2005 Oct; 96(3):533-42. PubMed ID: 16088945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
